HeartBeam Inc. (NASDAQ:BEAT)在2026年3月12日举行的2025年第四季度财报电话会议上公布了其商业化战略和产品路线图,重点介绍了近期获得的FDA批准以及针对高端礼宾心脏病学市场的集中发布策略。尽管公司报告第四季度净亏损530万美元,未达分析师预期,但其股价在盘后交易中上涨8.09%至1.39美元,反映出投资者对其战略定位和产品创新的乐观态度。 这家医疗器械公司获得了两 ...

Brian Humbarger, our new Chief Commercial Officer, will provide an overview of our limited commercial launch. Before we dive into updates since our last call in November, I want to remind everyone ...

HeartBeam Enters New Growth Phase Following FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment. First Commercial Partner ClearCardi ...

加州圣克拉拉 - HeartBeam Inc. (NASDAQ:BEAT)周二宣布与西奈山伊坎医学院合作,为其心脏监测平台开发AI心电图算法。该公司市值为5900万美元,今年迄今股价已下跌38%至1.48美元,但仍远高于52周低点0.54美元。 此次合作将结合HeartBeam的心电图平台与西奈山的临床数据和人工智能专业知识。该平台可从三个非共面维度捕捉心脏电活动。根据新闻稿,此次合作旨在开发用于 ...

(NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, announced a commercial partnership with ClearCardio (TM), a leading preventive ...

HeartBeam (NASDAQ: BEAT) announced a strategic collaboration with the Icahn School of Medicine at Mount Sinai in New ...

HeartBeam CEO Robert Eno and CFO Timothy Cruickshank will attend the virtual Oppenheimer 36th Annual Healthcare MedTech & Services Conference on March 16-17, 2026. Management will host a presentation ...

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through advanced cardiac ...

(NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced a strategic collaboration with the Icahn School of Medicine at ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D vector electrocardiogram (VECG) platform intended for ...

HeartBeam, Inc. BEAT shares are trading higher Tuesday after the company announced a strategic partnership with Mount Sinai to accelerate the joint development and validation of next-generation AI-ECG ...

HeartBeam (NASDAQ:BEAT) announced a strategic collaboration with the Icahn School of Medicine at Mount Sinai aimed at accelerating the development and clinical validation of next-generation artificial ...